In this article from the National Institute of Justice’s (NIJ) “Notes from the Field” series, Alex J. Krotulski, associate director of the Center for Forensic Science Research & Education (CFSRE), discusses the importance of non-targeted testing to keep pace with a rapidly evolving synthetic opioid market. He explains how with support from NIJ, the CFSRE and its scientists were able to demonstrate how novel sample-mining and data-mining workflows are valuable tools for the early identification and discovery of novel psychoactive substances (NPS) and emerging drug trends. Krotulski details how the NIJ-funded NPS Discovery remains in operation as a national drug early warning system and warehouses an open-access database that allows laboratories to rapidly share and consume information on novel psychoactive substances as soon as they are found. The database also includes reports on other vital drug information, including detections in drug materials, demographics, geographical distribution, and impacts on drug using communities.
- Helping Identify Potential Drug-Related Deaths: What to Tell the Coroner or Medical Examiner's Office
- A determination of the aerosolization efficiency of drugs of abuse in a eutectic mixture with nicotine in electronic cigarettes
- Delta(8)-THC, THC-O Acetates and CBD-di-O Acetate: Emerging Synthetic Cannabinoids Found in Commercially Sold Plant Material and Gummy Edibles